UPC Analytics
DEEN
Übersicht · Eingereicht:

APL_44633/2024

DEVICE FOR TREATING NIGHT TIME BREATHING PROBLEMS

BerufungenHauptberufungCourt of AppealAppeal RoP220.2
Parteien

Kläger

  • [name redacted / not provided in excerpt]
Vertreter: Marleen van den Horst (La Gro Geelkerken Advocaten)

Beklagte

  • OrthoApnea S.L.
  • Vivisol B BV
Vertreter: Christophe Ronse (ALTIUS Advocaten)
Richter
  • Klaus GrabinskiPresident of the Court of Appeal
  • Peter BlokLegally qualified judge and Judge-rapporteur
  • Emanuela GermanoLegally qualified judge
Patente
  • EP2331036
CPC-Codes: A61F5/566

Sektor: Pharmaceutical & Medical

Ausgang
Abgewiesen
Eingereicht:
Erste Entscheidung: 21. Nov. 2024
Sprache:

Court of Appeal declared the appeal against the primary first-instance order inadmissible and rejected the appeal against the review order. The CoA clarified the rules on amendment of a case versus new arguments: not every new argument constitutes an amendment of case requiring leave under R.263 RoP; the nature or scope of the dispute must change. The anonymised respondent's claims relating to admissibility of new arguments were assessed. The case involves a patent infringement action before a Dutch-language division.